PREGNANCY IN POLYCYSTIC OVARY SYNDROME II

多囊卵巢综合症 II 的妊娠

• 批准号: 7951306
• 负责人: RICHARD S. LEGRO
• 金额: $ 1.16万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951306
• 关键词: Clinical Research; Clomiphene; Computer Retrieval of Information on Scientific Projects Database; Fertility; Funding; Grant; Institution; Letrozole; Live Birth; Ovarian; Patients; Polycystic Ovary Syndrome; Pregnancy; Protocols documentation; Randomized; Research; Research Personnel; Resources; Source; Syndrome; United States National Institutes of Health; Woman

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a multi-center protocol examining the effects of Clomiphene as opposed to Letrozole in the promotion of fertility in women with polycystic ovarian syndrome. A total of 750 patients will be randomized across a number of centers. The primary study endpoint is live birth after randomization to one or the other therapy.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 这是一项多中心方案，研究克罗米芬相对于来曲唑在促进多囊卵巢综合征女性生育能力方面的效果。总共 750 名患者将被随机分配到多个中心。主要研究终点是随机分配到一种或另一种治疗后的活产。